Santhera Pharmaceuticals Holding AG (SWX:SANN)
Switzerland · Delayed Price · Currency is CHF 15.22
-0.52 (-3.30%)
Jul 10, 2026, 5:30 PM CET
SWX:SANN Market Cap
SWX:SANN has a market cap or net worth of 227.94 million as of July 10, 2026. Its market cap has increased by 46.11% in one year.
Market Cap
227.94M
Enterprise Value
254.45M
Revenue
77.19M
Ranking
n/a
PE Ratio
n/a
Stock Price
15.22
Market Cap Chart
Since November 3, 2006, SWX:SANN's market cap has decreased from 357.28M to 227.94M, a decrease of -36.20%. That is a compound annual growth rate of -2.26%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 10, 2026 | 227.94M | 35.32% |
| Dec 30, 2025 | 168.45M | 0.68% |
| Dec 30, 2024 | 167.31M | 85.24% |
| Dec 29, 2023 | 90.32M | 19.92% |
| Dec 30, 2022 | 75.32M | 34.92% |
| Dec 30, 2021 | 55.82M | 3.51% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Bachem Holding AG | 5.55B |
| Idorsia | 1.58B |
| Basilea Pharmaceutica AG | 681.77M |
| Newron Pharmaceuticals | 245.51M |
| BioVersys AG | 161.59M |
| Molecular Partners AG | 120.41M |
| Xlife Sciences AG | 102.64M |
| MindMaze Therapeutics Holding | 27.47M |